Monday, June 30, 2025

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Nearly 50 Percent of Federal Panelists Making Dietary Recommendations Have Money Ties to Food Industry

by Natasha Hobley
money and food industry
About half of the members of a U.S. federal government panel that shapes dietary recommendations in the United States have significant financial ...

Pfizer Will Charge Patients $1,390 for COVID Anti-Viral Paxlovid

by Carolyn Hendler, JD
Paxlovid capsules
Pfizer, Inc. plans to charge consumers more than double the price charged to the U.S. government for its COVID-19 anti-viral drug nirmatrelvir-ritonavir, ...

U.S. Vaccine Industry Harvesting Blood from Horseshoe Crabs

by Rishma Parpia
horseshoe crabs
For many decades, the blue colored blood from horseshoe crabs has been harvested for purposes of medical research and for quality control ...

Private Equity Buyouts of Health Care Facilities Comes With Cost to Patients

by Natasha Hobley
disappearing doctors
The rising trend in burnout of health care workers in recent years has presented an opportunity for private equity corporations in the ...

Los Angeles School District Encourages Sick Students to Attend Classes

by Rishma Parpia
students boarding school bus
When Los Angeles Unified School District (LAUSD) in California reopened following the end of the COVID-19 public health emergency (PHE) declaration, public ...

EcoHealth Alliance Sued by Families for Funding Chinese Institute Linked to Mutant SARS-CoV-2

by Carolyn Hendler, JD
Chinese lab researcher
Family members of four people who died from COVID-19 are suing the New York-based non-profit EcoHealth Alliance and its president, Peter Daszak, ...

Novavax to Receive $350 Million for Cancelled COVID Vaccine Orders in Canada

by Rishma Parpia
Novavax COVID vaccines
According to a securities filing with the U.S. Securities and Exchange Commission (SEC) by Novavax Inc. of Gaithersburg, Maryland on June 30, ...

FDA Panel Endorses New Alzheimer’s Drug After Accelerated Approval

by Natasha Hobley
elderly man
The newest Alzheimer’s drug is on its way for full regulatory approval after a U.S. Food and Drug Administration (FDA) advisory panel ...

In this section

Search in Archive

Search in Site

To search in site, type your keyword and hit enter

Search
The Vaccine Reaction
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.